Moxonidin Hexal (Moxonidine)

• Moxonidine acts on the imidazoline I1 receptors to manage elevated blood pressure in various hypertension categories.
• Essential hypertension: reduces systolic and diastolic pressure in patients with primary hypertension.
• Mild to moderate hypertension: provides effective blood pressure control when lifestyle measures are insufficient.
• Resistant hypertension: may be added to existing regimens to achieve target pressures in patients not responding to other agents.

• Moxonidine selectively stimulates imidazoline I1 receptors located in the rostral ventrolateral medulla, decreasing sympathetic nervous system outflow. This reduction in central sympathetic activity leads to lowered peripheral vascular resistance and heart rate, resulting in a decrease in arterial blood pressure.

Moxonidine is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

• Dry mouth: sensation of oral dryness.
• Fatigue: feeling of tiredness or lack of energy.
• Dizziness: light‑headedness, especially on standing.
• Headache: mild to moderate cranial pain.
• Nausea: upset stomach with urge to vomit.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe hypotension: markedly low blood pressure requiring medical attention.
• Bradycardia: unusually slow heart rate.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Hepatic dysfunction: abnormal liver enzymes or jaundice.
• Cardiac arrhythmia: irregular heart rhythm.
• Syncope: sudden loss of consciousness.

• Patients should be evaluated for safety before initiating therapy and monitored during treatment.
• Monitor blood pressure: adjust dose based on response.
• Renal impairment: use with caution in reduced kidney function.
• Elderly patients: start at lower dose and titrate slowly.
• Avoid abrupt discontinuation: taper to prevent rebound hypertension.
• Contraindicated in severe hypotension: do not use if blood pressure is already low.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Moxonidine may interact with other medicines that affect blood pressure or central nervous system activity.

Major Interactions (Avoid)

• Other centrally acting antihypertensives (e.g., clonidine): risk of excessive hypotension.
• Monoamine oxidase inhibitors (MAOIs): may potentiate hypotensive effects.
• Potent CYP2D6 inhibitors: could increase moxonidine plasma levels.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response.
• Diuretics: additive blood‑pressure lowering effect.
• Alcohol: can enhance dizziness and hypotension.
• Beta‑blockers: may require closer blood pressure monitoring.